Australia
NIGO DESIGNS FIRST PENFOLDS GRANGE LIMITED-EDITION
An icon re-imagined. First-ever design takeover by cultural pioneer and Human Made Creative Director. ADELAIDE, Australia, Feb. 23, 2024 /PRNewswire/ -- Today Penfolds unveiled a new collaboration for Penfolds flagship wine, Grange. TheGrange by NIGO release celebrates the first-ever design take...
2024-02-23 15:07
1465
The Kingdom of Saudi Arabia unveils Zarqa Al Yamama - the inaugural Arabic Grand Opera
LONDON, Feb. 21, 2024 /PRNewswire/ -- Zarqa Al Yamama, the first Grand Opera produced by The Saudi Theater and Performing Arts Commission, one of the 11 sector specific commissions under the Ministry of Culture, was internationally unveiled at an exclusive event inLondon's historic Goldsmiths' Ha...
2024-02-21 21:40
1916
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World
* Glenmark will be responsible for further developing, registering, and commercializing Envafolimab inIndia, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America. * Jiangsu Alphamab and 3D Medicines will receive a low double digit Million US Dollar amount up to launch, additio...
2024-01-25 18:00
1892
Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy
The study confirms that Xanamem is a brain-penetrant inhibitor of the tissue cortisol synthesis enzyme, 11β-HSD1, with high levels of target occupancy at doses as low as 5 mg SYDNEY, Jan. 24, 2024 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that its human Positron Emission Tom...
2024-01-24 21:30
1649
FDA CLEARANCE OF AMPLIA'S IND FOR PANCREATIC CANCER TRIAL IN US
HIGHLIGHTS * The US FDA has cleared Amplia's Investigational New Drug (IND) Application for a clinical trial of narmafotinib in theUSA * The proposed trial would explore the combination of narmafotinib and FOLFIRINOX in advanced pancreatic cancer patients in theUSA MELBOURNE, Australia ,Jan. ...
2024-01-18 10:31
1343
Style3D Research Shines the Show with additional Two Papers Accepted at SIGGRAPH ASIA 2023 on Cloth Simulation Innovations
SYDNEY, Jan. 10, 2024 /PRNewswire/ -- The electrifying stage of SIGGRAPH Asia 2023 witnessed Style3D Research's triumphant unveiling of two groundbreaking research papers through captivating oral presentations. This pinnacle gathering, renowned as a global hub for computer graphics, provided the ...
2024-01-11 02:00
1686
Seeing Machines unveils latest Guardian technology at CES 2024
- Guardian is the company's world-leading Aftermarket Driver Monitoring System for commercial vehicles and is currently connected to 54,000 vehicles globally - The new version includes Drowsiness Detection with refined microsleep detection and eye-gaze tracking to protect drivers fro...
2024-01-09 21:00
1549
Canadian Solar's e-STORAGE to Deliver 220 MWh DC of Battery Storage Solutions to Epic Energy's Mannum Project in South Australia
GUELPH, ON, Jan. 8, 2024 /PRNewswire/ -- Canadian Solar Inc
2024-01-08 20:05
1310
Recurrent Energy Completes Sale of 100 MW/200 MWh Battery Energy Storage Project in South Australia to Epic Energy
GUELPH, ON, Jan. 8, 2024 /PRNewswire/ -- Canadian Solar Inc.
2024-01-08 20:00
1543
GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN
ADELAIDE, Australia, Jan. 3, 2024 /PRNewswire/ -- GPN Vaccines Ltd, a clinical-stage biotechnology company developing a Streptococcus pneumoniae vaccine to prevent life-threatening pneumonia, bacteraemia and meningitis, is pleased to announce positive safety and immunogenicity data from its Phase...
2024-01-04 04:30
1856
APL-2301, a compound developed by Asieris for the treatment of Acinetobacter baumannii infection, was approved for Phase I clinical trials in Australia
SHANGHAI, Dec. 24, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that its product, APL-23...
2023-12-24 17:53
2739
Following a digital Rebrand, Little Black Book Looks Back at a Decade of Exponential Growth and Record Turnover
* LBB reports continued growth in business in the UK and an acceleration in growth internationally with increased business in theUSA, Canada, Australia, India and Germany. * A record turnover for the business of £3.2m in 2022, with a turnover of around £4m forecast in 2023. * The world's le...
2023-12-20 04:16
1739
Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome
Highlights: * Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures * Improvements were consistently seen across clinically important aspects of Phelan-McDermid syndrome, including communication, behaviour, cognition/learning and socialis...
2023-12-18 19:00
1260
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project
* After a successful stage 1, Lunit INSIGHT MMG moves to prospective validation inAustralia's BreastScreen NSW Machine Reading Solution Project SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therape...
2023-12-11 22:30
1746
IonOpticks and Newomics broaden chromatography accessibility for Agilent mass specs, with Shimadzu pending
MELBOURNE, Australia, Dec. 6, 2023 /PRNewswire/ -- IonOpticks, the world leader in high performance liquid chromatography for mass spectrometry, is proud to announce an exciting collaboration with Newomics Inc. that has produced an interface solution for their flagship Aurora Series columns and A...
2023-12-07 07:04
1649
Registrational Phase III CLARIFY trial in prostate cancer commences
SYDNEY, Nov. 30, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce it has commenced its r...
2023-11-30 22:16
1465
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
HIGHLIGHTS * Undetectable levels of Prostate Specific Antigen (PSA) have been reported from the first patient with metastatic castrate-resistant prostate cancer (mCRPC) to ever receive two cycles of Clarity's67Cu-SAR-bisPSMA at the 8GBq dose level. PSA is a marker of tumour burden, clinical re...
2023-11-30 21:59
1614
Leading AI decisioning platform Rich Data Co successfully raises $17.5 million in Series B round to accelerate North America expansion
SYDNEY, Nov. 29, 2023 /PRNewswire/ -- Rich Data Co
2023-11-30 07:13
1410
Clarity's theranostic prostate cancer trial progresses at the highest dose level cohort
HIGHLIGHTS * Cohort 3 of the theranostic SECuRE trial investigating 64Cu/67 Cu-SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has enrolled and treated 3 participants who received therapy with67Cu-SAR-bisPSMA at the highest dose level of 12GBq. * No dose limiting toxicit...
2023-11-29 21:58
1531
Telstra Broadcast Services and BT Announce Strategic Alliance to Enhance Global Network Connectivity
Initial five-year agreement delivers expanded media and broadcast network footprint acrossAsia-Pacific and key regions worldwide, with enhanced access to global markets SYDNEY, Nov. 21, 2023 /PRNewswire/ -- Telstra Broadcast Services (TBS) and BT have entered into an initial five-year strateg...
2023-11-21 13:30
1424
Week's Top Stories
Most Reposted
Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 305 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 299 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
[Picked up by 296 media titles]
2024-11-15 15:25
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 283 media titles]
2024-11-20 09:00
Most Read
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
2024-11-15 15:25
8674
How "small apples" march into "big industry" in Yan'an
2024-11-15 17:39
5354
Yingli Solar's Global Product Workshops Launched in Malaysia
2024-11-15 21:40
4730
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
4681